Roche Dx Joins Spanish Personalized Med Study | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Roche Diagnostics said today that it is partnering with three Spanish entities, including two research institutes and the software developer Advance Biological Laboratories Therapy Edge Spain (ABL) to develop personalized antiviral treatment strategies for patients with chronic hepatitis C or B.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.